Cargando…
Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer
BACKGROUND: The aim of this study was to determine a predictive indicator of gemcitabine (GEM) efficacy in unresectable pancreatic cancer using tissue obtained by endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA). METHODS: mRNAs extracted from 35 pancreatic tubular adenocarcinoma...
Autores principales: | Ashida, Reiko, Nakata, Bunzo, Shigekawa, Minoru, Mizuno, Nobumasa, Sawaki, Akira, Hirakawa, Kosei, Arakawa, Tetsuo, Yamao, Kenji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705349/ https://www.ncbi.nlm.nih.gov/pubmed/19531250 http://dx.doi.org/10.1186/1756-9966-28-83 |
Ejemplares similares
-
Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone
por: Murata, Akihiro, et al.
Publicado: (2013) -
Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer
por: Nakata, Bunzo, et al.
Publicado: (2010) -
Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) with Image Enhancement
por: Itonaga, Masahiro, et al.
Publicado: (2020) -
Clinical impact of preoperative endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma
por: Tsutsumi, Hideharu, et al.
Publicado: (2016) -
Utility of Forward-View Echoendoscopy for Transcolonic Fine-Needle Aspiration of Extracolonic Lesions: An Institutional Experience
por: Thinrungroj, Nithi, et al.
Publicado: (2020)